Skip to content

NT-proBNP as a Tool for the Detection of Acute Pulmonary Artery Embolism (APE)

NT-proBNP: a Useful Tool for the Detection of Acute Pulmonary Artery Embolism in Post-surgical Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01633671
Enrollment
44
Registered
2012-07-04
Start date
2008-11-30
Completion date
2011-12-31
Last updated
2012-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Embolism, Pulmonary Embolism Without Mention of Acute Cor Pulmonale

Keywords

Misadventures to Patients During Surgical and Medical Care, Pulmonary Embolism Without Acute Cor Pulmonale, Pulmonary Embolism Without Mention of Acute Cor Pulmonale

Brief summary

In patients with suspected APE (Acute Pulmonary Embolism) referred to the intensive care unit (ICU)after major surgery, serum NT-proBNP (N-terminal proBNP), Troponin-I and D-dimers were measured according to the standard hospital protocol. To definitively confirm or exclude APE, all patients underwent an angiographic CT-scan of the thorax.

Detailed description

In patients with suspected APE referred to the intensive care unit after major surgery, serum NT-proBNP, Troponin-I and D-dimers were measured according to the standard hospital protocol. Blood samples were obtained within one hour after the onset of clinical symptoms. Definitive confirmation or exclusion of APE was performed with an angiographic CT-scan of the thorax.

Interventions

None listed

Sponsors

University of Ulm
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

all patients referred to the ICU with suspected APE

Exclusion criteria

none

Design outcomes

Primary

MeasureTime frame
Acute pulmonary embolism: CT-proof yes vs. no1 hour after onset of clinical symptoms

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026